Calithera Biosciences Inc Shares Approach 52-Week Low - Market Mover

The shares closed 1.7% above its 52-week low of $2.31, with trading volume lower than its 30 day average

Apr 08, 2021 by Kwhen Finance Editors

Calithera Biosciences Inc Shares Approach 52-Week Low - Market Mover
Calithera Biosciences Inc shares closed today at 1.7% above its 52 week low of $2.31, giving the company a market cap of $176M. The stock is currently down 50.9% year-to-date, down 60.0% over the past 12 months, and down 57.5% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 2.0%.

Trading Activity

  • Trading volume this week was 10.1% lower than the 20-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.
  • The stock closed at 3.4% lower than its 5-day moving average, 9.1% lower than its 20-day moving average, and 31.3% lower than its 90-day moving average.

Market Comparative Performance

  • The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
  • The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Calithera Biosciences Inc-2.5-50.9-60.0-70.83.5
Dow Jones Industrial Average0.810.145.9-0.149.9
S&P 500 Index0.79.651.5-0.052.9
Health Care1.02.927.4-2.529.5

Peer Group Comparative Performance

  • The company's stock price performance year-to-date lags the peer average by -236.0%
  • The company's stock price performance over the past 12 months lags the peer average by -480.5%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Calithera Biosciences IncCALA0-50.9-60.0-70.83.5
Peer AvgN/A164.937.415.8-40.094.8
Gilead Sciences, Inc.GILD665.612.9-9.6-21.216.2
CASI Pharmaceuticals IncCASI-5.9-30.58.5-47.440.4
Pieris Pharmaceuticals IncPIRS011.29.9-21.446.7
Aeterna Zentaris Inc.AEZS0156.254.3-69.9275.9

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: